scispace - formally typeset
A

Anirban Das

Researcher at University of Toronto

Publications -  104
Citations -  816

Anirban Das is an academic researcher from University of Toronto. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 11, co-authored 76 publications receiving 424 citations. Previous affiliations of Anirban Das include Tata Memorial Hospital & Post Graduate Institute of Medical Education and Research.

Papers
More filters
Journal ArticleDOI

Global Retinoblastoma Presentation and Analysis by National Income Level

Ido Didi Fabian, +476 more
- 01 May 2020 - 
TL;DR: This cross-sectional analysis reports the retinoblastoma stage at diagnosis across the world during a single year, investigates associations between clinical variables and national income level, and investigates risk factors for advanced disease at diagnosis.
Journal ArticleDOI

Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency

TL;DR: In this paper , the authors reported on the ICI treatment of 45 progressive or recurrent tumors from 38 patients and reported a 3-year survival of 41.4% for most patients.
Journal ArticleDOI

Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency

TL;DR: In this article , the authors reported on the ICI treatment of 45 progressive or recurrent tumors from 38 patients and reported a 3-year survival of 41.4% for most patients.
Journal ArticleDOI

Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance.

Carol Durno, +105 more
TL;DR: In this paper, the authors defined mismatch repair deficiency syndrome (CMMRD) as a lethal cancer predisposition syndrome characterized by early-onset synchronous and metachronous multiorgan tumors.
Journal Article

A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.

TL;DR: Talc is slurry and povidone iodine is equally effective and safe pleurodesing agent for symptomatic malignant pleural effusion, however povodone iodine can be preferred option because of easy availability and low cost.